ArticleSurgical endoscopy2025
Outcomes after per oral pyloromyotomy based on gastroparesis etiology.
Article in Surgical endoscopy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPer oral pyloromyotomy (POP) has been shown to be effective in patients with gastroparesis. The three most common etiologies of gastroparesis are diabetic, postsurgical, and idiopathic. Our aim was to compare outcomes after POP based on the etiology of gastroparesis.
methodsThis was a retrospective cohort study of all patients that underwent POP between 2018 and 2023 at a single tertiary academic center. Patient factors such as demographics, previous interventions, and preoperative symptoms were compared between patients of diabetic, post-surgical, and idiopathic gastroparesis. Primary outcomes of interest included postoperative symptoms, recurrence, time to recurrence, and reinterventions.
resultsA total of 46 patients were included in the study of which 12 had diabetic, 23 had post-surgical, and 11 had idiopathic. The overall median age was 56.5 with a female predominance (61%). Twenty patients (43%) had previous endoscopic intervention, 2 (4%) had prior surgical intervention, and 15 (33%) were on medications at the time of referral. Patients had a median of 2 symptoms preoperatively, the most common being nausea (83%) and emesis (76%). There was no difference in demographic and preoperative factors between patients with different etiologies. There was an overall decrease in the number of symptoms for all patients (p < 0.001). There was no difference in postoperative symptoms between cohorts. Fourteen (33%) patients had recurrence of symptoms over a median of 6.5 months with 5 (11%) patients having another endoscopic intervention and 3 (7%) patients having surgical intervention. There were no differences in outcomes between the groups.
conclusionsIn our limited cohort, there were no differences in preoperative factors or postoperative outcomes for patients undergoing POP for different etiologies of gastroparesis. There was no differences in recurrence rate or in duration until recurrence. Patients with different etiologies of gastroparesis benefit similarly from POP.
Indexed as
Identifiers
39702568What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.